MedPath

SANDOZ MIGLUSTAT

SANDOZ MIGLUSTAT

Approved
DIN Number

02456257

Drug Class

Human

Market Date

Apr 20, 2020

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02456257
AIG Number0150021001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A16AX06 MIGLUSTAT
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification92:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

MIGLUSTATActive
Strength: 100 MG
Monograph: MIGLUSTAT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.